News from Finsen Laboratory

​Read the latest news about our research.

​

Award winner on the hunt for leukaemia’s evil root

Canadian Dr. John E. Dick is to receive Rigshospitalet’s International KFJ Award, and part of the honour is for his work in the fight against leukaemia.

Big data enables new treatment of aggressive cancers

Researchers from the Finsen Laboratory and BRIC in collaboration with researchers from Germany and Norway have developed a new computational method for analysis of large data material from thousands of cancer patients. These ‘big data’ can be used to understand how cancer genes are activated which enables targeted therapy especially for patients with aggressive tumours

Researchers develop antibody to save cancerous bones

​A research group lead by Dr. Niels Behrendt and Dr. Lars Engelholm from the Finsen Laboratory and BRIC shows that Osteosarcoma cells degrade the bone tissue through a completely different process than metastasised bone cancer. Through treatment with a specific antibody, the researchers blocked the process and reduced up to 80% of bone degradation in a cancer mouse model.

Stem-cell protein guarantees life-long blood production

​A group of researchers at the Finsen Laboratory, Rigshospitalet and BRIC, University of Copenhagen has discovered how a single protein within our blood stem cells, is critical for the ability to uphold the enormous blood production throughout our entire lifetime. The discovery can also provide new knowledge about how to treat diseases in our bone marrow and blood.
​

​


Responsible editor
Webgruppen på Rigshospitalet